Share on Pinterest A follow-up study indicates that aspirin should not be recommended to older adults for cancer prevention. Image credit: Yulia Naumenko/Getty Images A new study suggests that ...

The findings also indicate that those assigned to aspirin had a higher risk of cancer-related mortality during the trial. However, the results suggest that participants did not have any long-term ...

If you’ve ever found yourself scrolling through r/Constipation or r/WomensHealth at 2:00 a.m., you’ve likely seen the polarized world of MiraLAX Reddit threads. On one side, users hail the ...

A large Danish trial analysis suggests high-dose flu vaccines may offer extra protection against serious influenza-related hospitalizations in seniors. Study: High-Dose vs Standard-Dose Influenza ...

Despite his doctors’ recommendations, President Trump takes a high dose. By Nina Agrawal President Trump takes a high daily dose of aspirin, and has done so for over two decades, rejecting medical ...

Now, before I get into it, I will preface this review by saying my liver was fine to begin with. And if my liver were to give me issues, I would go to a doctor (as you should too!) before ever turning ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet. The study found that one ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

HOUSTON -- Rate of successful kidney transplantation was similar in adults, ages 65 and older, who received a lower dose immunosuppression regimen, according to the OPTIMIZE trial. For the study, 379 ...

A second dose conferred an additional 67.9% effectiveness against any herpes zoster outcome. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are effective in older adults, including ...

Participants were Medicare beneficiaries aged 65 years or older with continuous Part D coverage, with no prior RZV vaccination. HealthDay News — Two doses of the recombinant zoster vaccine (RZV) are ...

Compared to standard-dose influenza vaccines, Efluelda/Fluzone High-Dose demonstrated a reduction in laboratory-confirmed influenza hospitalizations by an additional 31.9% (95% CI, 19.7 to 42.2; ...